Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4

BACKGROUND: The Oxaliplatin plus 5-Fluorouracil /Leucovorin (FOLFOX4) regimen have been approved by Chinese Food and Drug Administration (CFDA), and covered by health insurance for patients with advanced hepatocellular carcinoma (HCC) in China. However, the efficacy of FOLFOX4 for HCC patients is st...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Asian Pac J Cancer Prev
Hoofdauteurs: Qin, Shukui, Zhang, Xinji, Guo, Wei, Feng, Jian, Zhang, Tianyi, Men, Lichuang, He, Jia
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: West Asia Organization for Cancer Prevention 2017
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5555527/
https://ncbi.nlm.nih.gov/pubmed/28610406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.5.1225
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items